WELLINGTON MANAGEMENT GROUP LLP - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 48 filers reported holding UNUM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$1,055,000
-45.1%
732,9670.0%0.00%
Q2 2019$1,920,000
-40.3%
732,9670.0%0.00%
-100.0%
Q1 2019$3,218,000
-0.2%
732,9670.0%0.00%0.0%
Q4 2018$3,225,000
-60.3%
732,967
-7.2%
0.00%
-50.0%
Q3 2018$8,132,000
-31.8%
789,467
-4.9%
0.00%
-33.3%
Q2 2018$11,916,000
+29.2%
830,3640.0%0.00%
+50.0%
Q1 2018$9,225,000830,3640.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$37,347,00028.23%
Novo Holdings A/S 665,181$31,669,0003.97%
New Leaf Venture Partners, L.L.C. 550,000$6,111,0003.30%
SECTORAL ASSET MANAGEMENT INC 1,081,545$12,016,0001.32%
SABBY MANAGEMENT, LLC 1,106,445$12,292,0000.73%
Monashee Investment Management LLC 175,000$1,944,0000.54%
DC Investments Management, LLC 35,524$395,0000.26%
Athanor Capital, LP 22,300$248,0000.12%
PLATINUM INVESTMENT MANAGEMENT LTD 225,000$2,499,0000.07%
Schonfeld Strategic Advisors LLC 73,000$811,0000.06%
View complete list of UNUM THERAPEUTICS INC shareholders